Early Waking: What Could Be Causing It

What Counts as Early Waking?

Clinicians define early morning awakening (EMA) as consistently waking at least 30 minutes before the intended rise time with an inability to fall back asleep. The International Classification of Sleep Disorders, Third Edition (ICSD-3) classifies EMA as one subtype of chronic insomnia disorder when it persists for three or more months and causes daytime impairment 1.

Terminal Insomnia vs. Sleep-Onset Insomnia

Sleep-onset insomnia involves trouble falling asleep at bedtime. Terminal insomnia, the clinical name for EMA, involves a normal sleep onset but premature final awakening. The distinction matters because the two patterns often have different underlying drivers. Sleep-onset insomnia correlates more with anxiety and hyperarousal at night, while EMA is more tightly linked to depression, advanced circadian phase, and cortisol dysregulation 2.

How Common Is It?

Population surveys suggest that 10 to 15 percent of adults report EMA at least three nights per week. In a large European cross-sectional study (N=18,980), early morning awakening was reported by 11.5 percent of respondents, with prevalence rising sharply after age 55 3. Women report EMA roughly 1.5 times more often than men across every age bracket studied.

Depression and Mood Disorders

Of all medical causes of early waking, major depressive disorder (MDD) has the strongest and best-documented association. Polysomnographic studies consistently show that depressed patients have shortened REM latency, reduced slow-wave sleep, and premature final awakening 4.

The REM-Sleep Connection

In MDD, the first REM period arrives earlier in the night (often within 45 minutes of sleep onset versus the typical 90 minutes), and REM density increases across the night. This architectural shift compresses restorative non-REM sleep into fewer cycles, making the brain more prone to cortical arousal during the final sleep cycle. A meta-analysis of 177 polysomnographic studies confirmed that shortened REM latency is one of the most reliable biological markers of depression 4.

Bipolar Disorder and Seasonal Patterns

Early waking also presents in bipolar depression and seasonal affective disorder. In bipolar disorder, circadian instability is thought to be a core feature rather than a symptom. Light-dark sensitivity and clock gene polymorphisms (CLOCK, PER3) may predispose certain individuals to both mood cycling and fragmented terminal sleep 5.

"Insomnia, and early morning awakening in particular, should prompt a mood disorder screening in any patient over 40 presenting with a new sleep complaint," notes the American Academy of Sleep Medicine clinical practice guideline on insomnia evaluation 6.

Circadian Rhythm Disorders

The body's master clock in the suprachiasmatic nucleus (SCN) drifts earlier with age. This phenomenon, called advanced sleep-wake phase disorder (ASWPD), explains why many older adults fall asleep at 8:00 PM and wake at 3:00 or 4:00 AM feeling unable to return to sleep 7.

Age-Related Phase Advance

Core body temperature nadir, a proxy for circadian phase, shifts approximately 1 hour earlier per decade after age 50 in longitudinal data. Dim-light melatonin onset (DLMO) testing confirms this forward shift. A study in the Journal of Clinical Endocrinology & Metabolism (N=34, age 65 to 81) found that DLMO occurred 1.2 hours earlier in older adults compared with younger controls, directly predicting earlier spontaneous wake time 8.

Light Exposure and Social Jet Lag

Insufficient evening light and excessive early-morning light reinforce the advanced phase. People who spend most daylight hours indoors under dim artificial light lose the photic cues that anchor circadian timing. Strategic bright-light therapy (2,500 to 10,000 lux) administered in the evening between 7:00 and 9:00 PM can delay the circadian clock by 30 to 90 minutes over two to four weeks 9.

Obstructive Sleep Apnea and Sleep-Disordered Breathing

Obstructive sleep apnea (OSA) is often considered a cause of nighttime awakenings and loud snoring, but it also drives early waking. REM sleep predominates in the final third of the night, and REM-related OSA (in which upper-airway muscle tone drops most) produces the worst oxygen desaturations during those early-morning hours 10.

Who Gets Missed?

The Lancet Respiratory Medicine estimated that 936 million adults worldwide aged 30 to 69 have mild-to-severe OSA, with roughly 425 million at moderate-to-severe levels 11. Yet up to 80 percent remain undiagnosed. Patients with a normal BMI, female patients, and those who do not snore loudly are frequently overlooked. Early waking with unrefreshing sleep and morning headache should prompt OSA screening even without classic risk factors.

Testing

Home sleep apnea testing (HSAT) or in-lab polysomnography (PSG) provides a definitive apnea-hypopnea index (AHI). An AHI of 5 or more events per hour, combined with symptoms, meets the AASM diagnostic threshold 12.

Cortisol and HPA Axis Dysregulation

Cortisol follows a predictable diurnal curve: it reaches its nadir near midnight, then rises sharply between 4:00 and 6:00 AM in what is called the cortisol awakening response (CAR). In individuals with chronic stress, anxiety disorders, or Cushing syndrome, this rise may be exaggerated or mistimed, pushing the brain into a wake-ready state before the alarm rings 13.

Stress and the CAR

A meta-analysis of 80 studies found that perceived life stress amplifies the CAR by an average of 22 percent, independent of sleep duration 13. The practical result: early cortical arousal, elevated heart rate on waking, and difficulty returning to sleep.

When Cortisol Testing Helps

Salivary cortisol sampling at four time points across the day (waking, waking + 30 minutes, afternoon, bedtime) can reveal a flattened or phase-advanced curve. This testing is especially useful when early waking co-occurs with weight gain, glucose intolerance, or fatigue that worsens despite adequate sleep opportunity.

Hormonal Changes: Menopause, Thyroid, and Testosterone

Hormonal shifts are among the most underdiagnosed contributors to early waking.

Menopause and Perimenopause

The Study of Women's Health Across the Nation (SWAN), a longitudinal cohort of 3,302 women, found that the odds of reporting sleep disruption rose 1.3-fold during the menopausal transition and 1.6-fold in postmenopause compared with premenopause, independent of vasomotor symptoms 14. Declining estradiol reduces serotonin and GABA signaling in sleep-regulating nuclei, and hot flashes fragment the second half of the night preferentially.

The North American Menopause Society (NAMS) 2022 position statement recommends hormone therapy as an option for sleep disruption attributable to vasomotor symptoms 15.

Thyroid Dysfunction

Both hyperthyroidism and hypothyroidism alter sleep. Hyperthyroidism shortens total sleep time and increases sympathetic tone, making early waking more likely. Hypothyroidism, paradoxically, can cause fragmented and unrefreshing sleep through reduced slow-wave sleep percentage 16. A TSH test is a reasonable baseline screen for any patient presenting with new-onset EMA.

Low Testosterone

In men, testosterone levels follow a circadian pattern peaking in early morning. Hypogonadal men report higher rates of insomnia and sleep fragmentation. A cross-sectional analysis of 1,312 men from the Framingham Heart Study cohort found that men in the lowest testosterone quartile had a 1.7-fold increased odds of reporting poor sleep quality 17.

Medications and Substances

Several commonly prescribed drugs cause early waking as a side effect.

Antidepressants

SSRIs (particularly fluoxetine and sertraline) can fragment sleep and reduce REM, sometimes producing a paradoxical increase in EMA despite treating the depression driving it. Bupropion, a norepinephrine-dopamine reuptake inhibitor, is especially activating and commonly causes early waking during the first weeks of therapy 18.

Beta-Blockers

Propranolol and atenolol cross the blood-brain barrier and suppress nocturnal melatonin secretion by up to 80 percent. A randomized crossover trial (N=17) showed that atenolol reduced nighttime melatonin and increased nocturnal wakefulness by 42 minutes compared with placebo 19.

Alcohol

Alcohol accelerates sleep onset but disrupts the second half of the night. As blood alcohol clears (roughly 3 to 5 hours after the last drink), a rebound sympathetic surge triggers cortical arousal. A meta-analysis of 27 studies confirmed that even moderate alcohol intake (one to two drinks) significantly increases wakefulness after sleep onset in the second half of the night 20.

Corticosteroids

Prednisone and dexamethasone administered even once daily in the morning can amplify the cortisol awakening response and push wake time earlier. Patients on chronic steroid therapy frequently report 4:00 to 5:00 AM awakenings.

Other Medical Conditions

Chronic Pain

Arthritis, fibromyalgia, and neuropathic pain intensify during the early-morning hours as endogenous opioid and anti-inflammatory signaling wane. Pain-related arousals cluster in the last two sleep cycles, producing what patients describe as "waking up with the pain."

Gastroesophageal Reflux Disease (GERD)

Nocturnal acid reflux worsens in the supine position and during the low-swallowing-rate environment of sleep. A study of 1,000 adults with confirmed GERD found that 74 percent reported nighttime symptoms and 40 percent reported early waking at least three nights per week 21.

Heart Failure

Paroxysmal nocturnal dyspnea and Cheyne-Stokes respiration both fragment late-night sleep. In patients with left ventricular ejection fraction <40 percent, central sleep apnea prevalence approaches 30 to 40 percent, with events clustering in the second half of the night 22.

How Early Waking Is Diagnosed

Evaluation begins with a structured sleep history. Clinicians typically ask about bedtime, sleep latency, number of awakenings, final wake time, and total sleep time.

Sleep Diaries and Actigraphy

A two-week sleep diary remains the gold-standard behavioral assessment tool recommended by the AASM. Wrist actigraphy can supplement diary data by providing objective rest-activity patterns over 7 to 14 days 23.

Questionnaires

The Insomnia Severity Index (ISI), a 7-item self-report scale, is validated for screening and tracking treatment response. A score of 15 or higher (out of 28) indicates moderate clinical insomnia warranting intervention 24.

When Polysomnography Is Needed

PSG is not routinely indicated for uncomplicated insomnia. It is reserved for cases where sleep apnea, periodic limb movement disorder, or narcolepsy is suspected, or when initial treatment fails after adequate trial 12.

Evidence-Based Treatments

Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I is the first-line treatment for chronic insomnia, including early waking, per both the AASM and the American College of Physicians (ACP). A landmark meta-analysis of 20 randomized controlled trials (N=1,162) found that CBT-I reduced wake after sleep onset by a mean of 26 minutes and improved sleep efficiency by 9.9 percentage points, with effects maintained at 12-month follow-up 25.

"We recommend that all adult patients with chronic insomnia disorder receive CBT-I as the initial treatment," states the ACP 2016 clinical practice guideline 26.

Sleep Restriction Therapy

A core component of CBT-I, sleep restriction limits time in bed to match actual sleep time, consolidating sleep pressure into fewer hours. Over two to four weeks, time in bed is gradually extended as sleep efficiency improves beyond 85 percent.

Pharmacotherapy

When CBT-I is insufficient or unavailable, short-term pharmacotherapy may help. Options include:

• Suvorexant (Belsomra) and lemborexant (Dayvigo): Dual orexin receptor antagonists that reduce wakefulness without suppressing slow-wave sleep. Lemborexant 5 mg reduced wake after sleep onset by 25 minutes vs. Placebo in the SUNRISE-2 trial (N=949) at 6 months 27.
• Low-dose doxepin (Silenor, 3 to 6 mg): FDA-approved specifically for sleep maintenance insomnia. It selectively blocks H1 receptors at low doses without significant anticholinergic effects.
• Extended-release melatonin (2 mg): Approved in Europe for adults over 55. Helps re-anchor circadian timing, particularly in age-related phase advance.

Bright-Light Therapy

For circadian-driven EMA, evening bright-light exposure (7:00 to 9:00 PM, 10,000 lux for 30 minutes) can delay the circadian clock and push wake time later. A randomized trial in older adults (N=30, mean age 67) showed a 52-minute delay in spontaneous wake time after three weeks of evening light therapy 9.

Treating the Underlying Condition

When EMA is secondary to depression, OSA, GERD, or a hormonal imbalance, treating the root cause often resolves the sleep complaint. CPAP adherence of four or more hours per night reduces AHI to <5 in most OSA patients, and REM-related events in the early-morning hours resolve first 10.

When to See a Doctor

Occasional early waking after a stressful event does not require medical evaluation. Seek evaluation when EMA occurs three or more nights per week for at least three months, impairs daytime functioning (concentration, mood, work performance), or co-occurs with symptoms like unintentional weight change, morning headaches, excessive daytime sleepiness, or depressed mood. Early waking paired with suicidal ideation requires immediate psychiatric assessment.

Adults over 50 experiencing a new pattern of 4:00 to 5:00 AM awakenings should have, at minimum, a TSH level, fasting glucose, and depression screen (PHQ-9) performed, with sleep apnea testing if snoring, witnessed apneas, or an Epworth Sleepiness Scale score of 10 or higher are present.